| 36.46 Delayed Data As of Oct 17 |  +0.12 / +0.33%Today’s Change | 33.97 Today|||52-Week Range 46.47 | -16.47% Year-to-Date |
| 3 Dividend-Paying Pharma Stocks to Buy Now Oct 15 / MotleyFool.com - Paid Partner Content | Here's Why Akcea Therapeutics Jumped 30% Today Oct 07 / MotleyFool.com - Paid Partner Content |
| 3 Top Healthcare Dividend Stocks That Are Great Picks for Retirees Oct 13 / MotleyFool.com - Paid Partner Content | A Cancer Diagnostics Company You Should Own Today Oct 01 / MotleyFool.com - Paid Partner Content |
| Big Pharma Has Mad Love For These 2 Biotechs Oct 11 / MotleyFool.com - Paid Partner Content | Better Buy: Gilead Sciences vs. Pfizer Sep 29 / MotleyFool.com - Paid Partner Content |
| 3 Big Pharma Stocks Driving Price Inflation Oct 10 / MotleyFool.com - Paid Partner Content | Where Will Pfizer Be in 5 Years? Sep 28 / MotleyFool.com - Paid Partner Content |
| Should Investors Buy or Sell Sangamo Therapeutics Right Now? Oct 08 / MotleyFool.com - Paid Partner Content | Is GlaxoSmithKline a Buy? Sep 27 / MotleyFool.com - Paid Partner Content |
| Previous close | 36.34 |
| Today’s open | 36.49 |
| Day’s range | 36.37 - 36.81 |
| Volume | 14,561,579 |
| Average volume (3 months) | 23,205,603 |
| Market cap | $199.7B |
| Earnings growth (last year) | -46.78% |
| Earnings growth (this year) | -5.92% |
| Earnings growth (next 5 years) | +4.40% |
| Revenue growth (last year) | +2.10% |
| P/E ratio | 16.7 |
| Price/Sales | 4.86 |
| Price/Book | 3.26 |
| Today’s change | Today’s % change | |
|---|---|---|
| NVSNovartis | +0.23 | +0.26% |
| MRKMerck | -0.65 | -0.77% |
| AZNAstraZeneca | +0.34 | +0.78% |
| SNYSanofi | +0.76 | +1.66% |
| Next reporting date | October 29, 2019 |
| EPS forecast (this quarter) | $0.62 |
| Annual revenue (last year) | $53.6B |
| Annual profit (last year) | $11.2B |
| Net profit margin | 20.77% |
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters New York, New York |
